• 1
    Dockray G. J. & Gregory R. A. Gastrin. In: MahkloufG. M., ed., Handbook of Physiology, Section 6: The Gastrointestinal System, Vol II: Neural and Endocrine Biology. American Physiological Society, Bethesda , 1989; 31136.
  • 2
    Rehfeld J. F. Cholecystokinin. In: MahkloufG. M., ed., Handbook of Physiology, Section 6: The Gastrointestinal System. Vol II: Neural and Endocrine Biology. American Physiological Society, Bethesda , 1989; 33758.
  • 3
    Ryberg B., Axelson J., Hakanson R., Sundler F. & Mattsson H. Trophic effects of continuous infusion of [Leu15]-gastrin-17 in the rat. Gastroenterology 1990; 98: 338.
  • 4
    Axelson J., Hakanson R., Ihse I., Lilja I., Rehfeld J. F. & Sundler F. Effects of endogenous and exogenous cholecystokinin and of infusion with the cholecystokinin antagonist L-364,718 on pancreatic and gastrointestinal growth. Scand. J. Gastroenterol. 1990; 25: 47180.
  • 5
    Silvente-Poirot S., Dufresne M., Vaysse N. & Fourmy D. The peripheral cholecystokinin receptors. Eur. J. Biochem. 1993; 215: 51329.
  • 6
    Ulrich C. D., Ferber I., Holicky E., Hadac E., Buell G. & Miller L. J. Molecular cloning and functional expression of the human gallbladder cholecystokinin A receptor. Biochem. Biophys. Res. Commun. 1993; 193: 20411.
  • 7
    De Weerth A., Pisegna J. R., Huppi K. & Wank S. A. Molecular cloning, functional expression and chromosomal localization of the human cholecystokinin type A receptor. Biochem. Biophys. Res. Commun. 1993; 194: 81118.
  • 8
    Chang R. S. L., Lotti V. J., Chen T. B., & Kunkel K. A. Characterization of the binding of [3H]-(±)-L-364,718: A new potent, nonpeptide cholecystokinin antagonist radioligand selective for peripheral receptors. Mol. Pharmacol. 1986; 30: 21317.
  • 9
    Lin C. W., Holladay M. W., Barrett R. W. et al. Direct requirements for activation at CCK-A and CCK-B/gastrin receptors: Studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30–33). Mol. Pharmacol. 1989; 36: 8816.
  • 10
    Lin C. W., Holladay M. W., Witte D. G. et al. A71378: A CCK agonist with high potency and selectivity for CCK-A receptors. Am. J. Physiol. 1990; 258: G64851.
  • 11
    Chang R. S. L., Lotti V. J., Monaghan R. L. et al. A potent nonpeptide cholecystokinin antagonist selective for peripheral tissues isolated from Aspergillus alliaceus. Science 1985; 230: 1779.
  • 12
    Lotti V. J. & Chang R. S. L. A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260. Eur. J. Pharmacol. 1989; 162: 27380.
  • 13
    Hughes J., Boden P., Costall B. et al. Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity. Proc. Natl Acad. Sci. USA 1990; 87: 672832.
  • 14
    Pisegna J. R., de Weerth A., Huppi K. & Wank S. A. Molecular cloning of the human brain and gastric cholecystokinin receptor: structure, functional expression and chromosomal localization. Biochem. Biophys. Res. Commun. 1992; 189: 296303.
  • 15
    Lee Y. M., Beinborn M., McBride E. W., Lu M., Kolakowski L. F. & Kopin A. S. The human brain cholecystokinin-B/gastrin receptor. Cloning and characterization. J. Biol. Chem. 1993; 268: 81649.
  • 16
    Ito M., Matsui M., Taniguchi T. et al. Functional characterization of a human brain cholecystokinin-B receptor. A trophic effect of cholecystokinin and gastrin. J. Biol. Chem. 1993; 268: 183005.
  • 17
    Hoosein N. M., Kiener P. A., Curry R. C., Rovati L. C., McGilbra D. K. & Brattain M. G. Antiproliferative effects of gastrin receptor antagonists and antibodies to gastrin on human colon carcinoma cell lines. Cancer Res. 1988; 48: 717983.
  • 18
    Blackmore M. & Hirst B. H. Autocrine stimulation of growth of AR4-2J rat pancreatic tumour cells by gastrin. Br. J. Cancer 1992; 66: 328.
  • 19
    Lees F. & Grandjean L. C. The gastric and jejunal mucosae in healthy patients with partial gastrectomy. Arch. Int. Med. 1968; 101: 943751.
  • 20
    Gjurldsen S. T., Myren J. & Fretheim B. Alterations of gastric mucosa following a graded partial gastrectomy. Scand. J. Gastroenterol. 1968; 3: 46570.
  • 21
    Johnson L. R. & Chandler A. M. RNA and DNA of gastric and duodenal mucosa in antrectomized and gastrintreated rats. Am. J. Physiol. 1973; 224: 93740.
  • 22
    Neuberger P., Lewin M. & Bonfils S. Parietal and chief cell populations in four cases of the Zollinger-Ellison Syndrome. Gastroenterology 1972; 63: 93742.
  • 23
    Pisegna J. R., Norton J. A., Slimak G. G. et al. Effects of curative gastrinoma resection on gastric secretory function and antisecretory drug requirement in the Zollinger-Ellison Syndrome. Gastroenterology 1992; 102: 76778.
  • 24
    Johnson L. R. The trophic action of gastrointestinal hormones. Gastroenterology 1976; 70: 27888.
  • 25
    Johnson L. R. Regulation of gastrointestinal mucosal growth. World J. Surg. 1979; 3: 47787.
  • 26
    Johnson L. R. Trophic effects of gut peptides. In: MakhloufG. M., ed., Handbook of Physiology, Section 6: The Gastrointestinal System. Vol II: Neural and Endocrine Biology. American Physiological Society, Bethesda , 1989; 291310.
  • 27
    Fölsch U. R. Regulation of pancreatic growth. Clin. Gastroenterol. 1984; 13: 67999.
  • 28
    Hakanson R., Oscarson J. & Sundler F. Gastrin and the trophic control of gastric mucosa. Scand. J. Gastroenterol. 1986; 21(Suppl. 118): 1830.
  • 29
    Crean G. P., Marshall M. W. & Rumsey R. D. E. Parietal cell hyperplasia induced by the administration of pentagastrin (ICI 50,123) to rats. Gastroenterology 1969; 57: 14755.
  • 30
    Balas D., Senegas-Balas F., Pradayrol L., Vayssette J., Bertrand C. & Ribet A. Long-term comparative effect of cholecystokinin and gastrin on mouse stomach, antrum, intestine, and exocrine pancreas. Am. J. Anat. 1985; 174: 2743.
  • 31
    McGregor D. B., Jones R. D., Karlin D. A. & Romsdahl M. M. Comparison of effects of pentagastrin and gastrin on rat colon mucosa. J. Surg. Res. 1983; 34: 32531.
  • 32
    Oscarson J., Hakanson R., Liedberg G., Lundqvist G., Sundler F. & Thorell J. Variated serum gastrin concentration: Trophic effects on the gastrointestinal tract of the rat. Acta Physiol. Scand. 1979; Suppl. 475: 227.
  • 33
    Chu M., Rehfeld J. F. & Borch K. Effects of gastric fundectomy and antrectomy on the colonic mucosa in the hamster. Digestion 1992; 53: 2834.
  • 34
    Sobhani I., Lehy T., Laurent-Puig P., Cadiot G., Ruszniewski P. & Mignon M. Chronic endogenous hypergastrinemia in humans: Evidence for a mitogenic effect on the colonic mucosa. Gastroenterology 1993; 105: 2230.
  • 35
    Mak K. M. & Chang W. W. L. Pentagastrin stimulates epithelial cell proliferation in duodenal and colonic crypts in fasted rats. Gastroenterology 1976; 71: 111720.
  • 36
    Fatemi S. H., Cullan G. E. & Sharp J. G. Evaluation of the effects of pentagastrin, gastrin and pancreatic glucagon on cell proliferation in the rat gastrointestinal tract. Cell Tissue Kinetics 1984; 17: 11933.
  • 37
    Ahnen D. J. & Bozdech J. Gastrin as a trophic hormone for the colon. In: WalshJ. H., ed., Gastrin. Raven, New York , 1993; 3016.
  • 38
    Rothman S. S. & Wells H. Enhancement of pancreatic enzyme synthesis by pancreozymin. Am. J. Physiol. 1967; 213: 21518.
  • 39
    Solomon T. E. Regulation of exocrine pancreatic cell proliferation and enzyme synthesis. In: JohnsonL. R., ed., Physiology of the Gastrointestinal Tract. Raven, New York , 1981; 87392.
  • 40
    Pfeiffer C. J., Chernenko G. A., Kohli Y. & Barrowman J. A. Trophic effects of cholecystokinin octapeptide on the pancreas of the Syrian hamster. Can. J. Physiol. Pharmacol. 1982; 60: 35862.
  • 41
    Satake K., Mukai R., Kato Y. & Umeyama K. Effects of cerulein on the normal pancreas and on experimental pancreatic carcinoma in the Syrian Golden hamster. Pancreas 1986; 1: 24653.
  • 42
    Niederau C., Liddle R. A., Williams J. A. & Grendell J. H. Pancreatic growth: Interaction of exogenous cholecystokinin, a protease inhibitor, and a cholecystokinin receptor antagonist in mice. Gut 1987; 28(Suppl. 1): 639.
  • 43
    Logsdon C. D. & Williams J. A. Pancreatic acinar cells in monolayer culture: direct trophic effects of caerulein in vitro. Am. J. Physiol. 1986; 250: G4407.
  • 44
    Logsdon C. D. Stimulation of pancreatic acinar cell growth by CCK, epidermal growth factor, and insulin in vitro. Am. J. Physiol. 1986; 251: G48793.
  • 45
    Logsdon C. D. Effects of calcium mediated secretagogues on the growth of pancreatic acinar cells in vitro. Gut 1987; 28(Suppl. 1): 11720.
  • 46
    Dawra R., Saluja A., Lerch M. M., Saluja M., Logsdon C. & Steer M. Stimulation of pancreatic growth by cholecystokinin is mediated by high affinity receptors on rat pancreatic acinar cells. Biochem. Biophys. Res. Commun. 1993; 193: 81420.
  • 47
    Povoski S. P., Zhou W., Longnecker D. S., Roebuck B. D. & Bell R. H. Stimulation of growth of azaserine-induced putative preneoplastic lesions in rat pancreas is mediated specifically by way of cholecystokinin-A receptors. Cancer Res. 1993; 53: 39259.
  • 48
    Dembinski A., Jaworek J., Konturek P. K., Konturek S. J. & Warzecha Z. Cholecystokinin receptor antagonism by peptidergic and non-peptdergic agents in rat pancreas. J. Physiol. 1989; 411: 41935.
  • 49
    Hajri A., Aprahamian M. & Damge C. Effect of a new CCK-receptor antagonist, CR 1409, on pancreatic growth induced by caerulein, CCK-8, bombesin and gastrin-releasing peptide in the rat. Digestion 1989; 43: 6672.
  • 50
    Scarpignato C., Varga G., Dobronyi I. & Papp M. Effect of a new potent CCK antagonist, Lorglumide, on caerulein- and bombesin-induced pancreatic secretion and growth in the rat. Br. J. Pharmacol. 1989; 96: 6619.
  • 51
    Meijers M., Appel M. J., Van Garderen-Hoetmer A. et al. Effects of cholecystokinin and bombesin on development of azaserine-induced pancreatic tumours in rats: Modulation by the cholecystokinin receptor antagonist lorglumide. Carcinogenesis 1992; 13: 15258.
  • 52
    Schmidt W. E., Choudhury A. R., Siegel E. G. et al. CCK-antagonist L-364,718: influence on rat pancreatic growth induced by caerulein and bombesin-like peptides. Reg. Peptides 1989; 24: 6779.
  • 53
    Zucker K. A., Adrian T. E., Bilchik A. J. & Modlin I. M. Effects of the CCK receptor antagonist L364,718 in pancreatic growth in adult and developing animals. Am. J. Physiol. 1989; 257: G51116.
  • 54
    Wisner J. R., McLaughlin R. E., Rich K. A., Ozawa S. & Renner I. G. Effects of L-364,718, a new cholecystokinin receptor antagonist, on camostate-induced growth of the rat pancreas. Gastroenterology 1988; 94: 10913.
  • 55
    Gasslander T., Axelson J., Hakanson R., Ihse I., Lilja I. & Rehfeld J. F. Cholecystokinin is responsible for growth of the pancreas after pancreaticobiliary diversion in rats. Scand. J. Gastroenterol. 1990; 25: 10605.
  • 56
    Nylander A. G., Chen D., Ihse I., Rehfeld J. F. & Hakanson R. Pancreatic atrophy in rats produced by the cholecystokinin-A receptor antagonist devazepide. Scand. J. Gastroenterol. 1992; 27: 7437.
  • 57
    Schmidt W. E., Stöckmann F., Choudhury A. R. et al. Influence of CCK antagonist L-364,718, pancreastatin (33–49) and a somatostatin analogue on camostate-induced rat pancreatic hypertrophy. Digestion 1989; 44: 10516.
  • 58
    Rivard N., Guan D., Maouyo D., Grondin G., Berube F. L. & Morisset J. Endogenous cholecystokinin release responsible for pancreatic growth observed after pancreatic juice diversion. Endocrinology 1991; 129: 286774.
  • 59
    Niederau C., Lüthen R., Niederau M., Strohmeyer G., Ferrell L. D. & Grendell J. H. Effects of long-term CCK stimulation and CCK blockade on pancreatic and intestinal growth, morphology, and function. Digestion 1990; 46(Suppl. 2): 21725.
  • 60
    Lamote J., Putz P. & Willems G. Effect of cholecystokinin-octapeptide, caerulein, and pentagastrin on epithelial cell proliferation in the murine gallbladder. Gastroenterology 1982; 83: 3717.
  • 61
    Morisset J. & Génik P. Effects of acute and chronic administration of secretin and caerulein on rat duodenal and gastric growth. Reg. Peptides 1983; 5: 11123.
  • 62
    Oscarson J. E. A., Veen H. F., Williamson R. C. N., Ross J. S. & Malt R. A. Compensatory postresectional hyperplasia and starvation atrophy in small bowel: Dissociation from endogenous gastrin levels. Gastroenterology 1977; 72: 8905.
  • 63
    Dembinski A. B. & Johnson L. R. Role of gastrin in gastrointestinal adaptation after small bowel resection. Am. J. Physiol. 1982; 243: G1620.
  • 64
    Tilson M. D. & Axtmayer A. Antral exclusion enhances compensatory hypertrophy of the gut after partial enterectomy. J. Surg. Res. 1976; 20: 2759.
  • 65
    Sagor G. R., Al-Mukhtar M. Y. T., Ghatel M. A., Wright N. A. & Blcom S. R. The effect of altered luminal nutrition on cellular proliferation and plasma concentrations of enteroglucagon and gastrin after small bowel resection in the rat. Br. J. Surg. 1982; 69: 1418.
  • 66
    Sagor G. R., Ghatel M. A., Al-Mukhtar Y. T., Wright N. A. & Bloom S. R. Evidence for a humoral mechanism after small intestinal resection. Gastroenterology 1983; 84: 9026.
  • 67
    Stock-Damge C., Aprahamian M., Lhoste E. et al. Pancreatic hyperplasia after small bowel resection in the rat: Dissociation from endogenous gastrin levels. Digestion 1984; 29: 22330.
  • 68
    Stock-Damge C., Lhoste E., Aprahamian M. & Pousse A. Gastrin modulation of pancreatic growth. Scand. J. Gastroenterol. 1985; 20(Suppl. 112): 6874.
  • 69
    Schedl H. P., Wilson H. D., Ramaswamy K. & Lichtenberger L. Gastrin and growth of the alimentary tract in the streptozotocin-diabetic rat. Am. J. Physiol. 1982; 242: G4603.
  • 70
    Goodlad R. A., Al-Mukhtar M. Y. T., Ghatei M. A., Bloom S. R. & Wright N. A. Cell proliferation, plasma enteroglucagon and plasma gastrin levels in starved and refed rats. Virchows Arch (Cell Path.) 1983; 43: 5562.
  • 71
    Nandi Majumdar A. P. Effects of fasting and refeeding on antral, duodenal, and serum gastrin levels and on colonic thymidine kinase activity in rats. Hormone Res. 1984; 19: 12734.
  • 72
    Haentjens P., Delvaux G., Chayvialle J. A. & Willems G. Postprandial stimulation of epithelial cell proliferation in defunctioned colon of rats is not caused by gastrin. Gastroeterology 1986; 90: 93945.
  • 73
    Chernick S. S., Lepkowsky S. & Chaikoff I. L. A dietary factor regulating the enzyme content of the pancreas: changes induced in size and proteolytic activity of the chick pancreas by the ingestion of raw soybean meal. Am. J. Physiol. 1948; 155: 3341.
  • 74
    Booth A. N., Robbins D. J., Ribelin W. E. & De Eds F. Effect of raw soybean meal and amino acids on pancreatic hypertrophy in rats. Proc. Soc. Exp. Biol. Med. 1960; 104: 6813.
  • 75
    Yonezawa H. Secretory responses of hypertrophied rat pancreas induced by repeated oral administrations of a synthetic protease inhibitor. Jpn. J. Physiol. 1983; 33: 18395.
  • 76
    Göke B., Siegel E. G., Stöckmann F., Lankisch P. G. & Creutzfeldt W. Effect of a specific serine protease inhibitor on the rat pancreas. Digestion 1985; 31: 12835.
  • 77
    Liddle R. A., Goldfine I. D. & Williams J. A. Bioassay of plasma cholecystokinin in rats: Effects of food, trypsin inhibitor, and alcohol. Gastroenterology 1984; 87: 5429.
  • 78
    Göke B., Printz H., Koop I. et al. Endogenous CCK release and pancreatic growth in rats after feeding a proteinase inhibitor (Camostate). Pancreas 1986; 1: 50915.
  • 79
    Roebuck B. D., Kaplita P. V., Edwards B. R. & Praissman M. Effects of dietary fats and soybean protein on azaserine-induced pancreatic carcinogenesis and plasma cholecystokinin in the rat. Cancer Res. 1987; 47: 13338.
  • 80
    Miazza B. M., Turberg Y., Guillaume P., Hahne W., Chayvialle J. A. & Loizeau E. Mechanism of pancreatic growth induced by pancreatico-biliary diversion in the rat. Inhibition by proglumide, benzotript and ranitidine. Scand. J. Gastroenterol. 1985; 20 (Suppl. 112): 7583.
  • 81
    Miazza B. M., Van Hung L., Vaja S. & Dowling R. H. Effect of pancreaticobiliary diversion (PBD) on jejunal and ileal structure and function in the rat. In: RobinsonJ. W. L., DowlingR. H., RieckenE. D., eds., Mechanisms of Intestinal Adaptation. MTP Press, Lancaster , 1982; 48190.
  • 82
    Lee P. C., Newman B. M., Praissman M., Cooney D. R. & Lebenthal E. Cholecystokinin: A factor responsible for the enteral feedback control of pancreatic hypertrophy. Pancreas 1986; 1: 33540.
  • 83
    Chu M., Borch K., Lilja I., Blomqvist L., Rehfeld J. F. & Ihse I. Endogenous hypercholecystokininemia model in the hamster: Trophic effect on the exocrine pancreas. Pancreas 1992; 7: 2205.
  • 84
    Watanapa P., Flaks B., Oztas H., Deprez P. H., Calam J. & Williamson R. C. N. Inhibitory effect of a cholecystokinin antagonist on pancreatic carcinogenesis after pancreaticobiliary diversion. Br. J. Cancer. 1993; 67: 6637.
  • 85
    Chen D., Anderson K., Iovanna J. L., Dagorn J. C. & Hakanson R. Effects of hypercholecystokininemia produced by pancreaticobiliary diversion on pancreatic growth and enzyme mRNA levels in starved rats. Scand. J. Gastroenterol. 1993; 28: 31114.
  • 86
    Chu M., Rehfeld J. F. & Borch K. Gastric fundic epithelial proliferation after pancreaticobiliary diversion. Digestion 1992; 51: 1339.
  • 87
    Miazza B. M., Widgren S., Chayvialle J. A., Nicolet T. & Loizeau E. Exocrine pancreatic nodules after longterm pancreaticobiliary diversion in rats. An effect of raised CCK plasma concentrations. Gut 1987; 28(Suppl. 1): 26973.
  • 88
    Watanapa P., Efa E. F., Beardshall K. et al. Inhibitory effect of a cholecystokinin antagonist on the proliferative response of the pancreas to pancreaticobiliary diversion. Gut 1991; 32: 104954.
  • 89
    Rosenberg L., Duguid W. P. & Fried G. M. Association of cholecystectomy with pancreatic growth and increased plasma levels of cholecystokinin in the Syrian golden hamster. J. Surg. Res. 1988; 44: 23541.
  • 90
    Watanapa P., Egan M., Deprez P. H. et al. Role of cholecystokinin in pancreatic adaptation to massive enterectomy. Gut 1992; 33: 95964.
  • 91
    Nandi Majumdar A. P., Vesenka G. D. & Dubick M. A. Acceleration of pancreatic regeneration by cholecystokinin in rats. Pancreas 1987; 2: 199204.
  • 92
    Jurkowska G., Grondin G. & Morisset J. Involvement of endogenous cholecystokinin in pancreatic regeneration after cerulein-induced acute pancreatitis. Pancreas 1992; 7: 295304.
  • 93
    Saluja A. K., Saluja M., Printz H., Zavertnik A., Sengupta A. & Steer M. L. Experimental pancreatitis is mediated by low-affinity cholecystokinin receptors that inhibit digestive enzyme secretion. Proc. Natl Acad. Sci. USA 1989; 86: 896871.
  • 94
    Creutzfeldt W. The achlorhydria-carcinoid sequence: Role of gastrin. Digestion 1988; 39: 6179.
  • 95
    Elsborg L. & Mosbech J. Pernicious anaemia as a risk factor in gastric cancer. Acta Med. Scand. 1979; 206: 31518.
  • 96
    Brinton L. A., Gridley G., Hrubec Z., Hoover R. & Fraumeni J. F. Cancer risk following pernicious anaemia. Br. J. Cancer 1989; 59: 81013.
  • 97
    Ganguli P. C., Cullen D. R. & Irvine W. J. Radioimmunoassay of plasma-gastrin in pernicious anaemia, chlorhydria without pernicious anaemia, hypochlorhydria and in controls. Lancet 1971; 1: 1558.
  • 98
    Talley J., Chute C. G., Larson D. E., Epstein R., Lydick E. G. & Melton L. J. Risk for colorectal adenocarcinoma in pernicious anemia. Ann. Int. Med. 1989; 111: 73842.
  • 99
    Helling T. S. & Wood W. G. Gastric carcinoids and atrophic gastritis. Arch. Surg. 1983; 118: 7658.
  • 100
    Carney J. A., Go V. L. W., Fairbanks V. F., Moore S. B., Alport E. C. & Nora F. E. The syndrome of gastric argyrophil carcinoid tumors and nonantral gastric atrophy. Ann. Int. Med. 1983; 99: 7616.
  • 101
    Nosaka T., Habu H., Endo M. & Okayasu I. Multiple carcinoid tumors of the stomach with hypergastrinemia. Am. J. Gastroenterol. 1992; 87: 76670.
  • 102
    Borch K., Renvall H. & Liedberg G. Endocrine cell proliferation and carcinoid development: A review of new aspects of hypergastrinaemic atrophic gastritis. Digestion 1986; 35(Suppl. 1): 10615.
  • 103
    Bordi C., Pilato F., Carfagna G. et al. Argyrophil cell hyperplasia of fundic mucosa in patients with chronic atrophic gastritis. Digestion 1986; 35(Suppl. 1): 13043.
  • 104
    Solcia E., Capella C., Sessa F. et al. Gastric carcinoids and related endocrine growths. Digestion 1986; 35(Suppl. 1): 321.
  • 105
    Hodges J. R., Isaacson P. & Wright R. Diffuse entero-chromaffin-like (ECL) cell hyperplasia and multiple gastric carcinoids: A complication of pernicious anaemia. Gut 1981; 22: 23741.
  • 106
    Bordi C., Cocconi G., Togni R., Vezzadini P. & Missale G. Gastric endocrine cell proliferation. Arch. Path. 1974; 98: 2748.
  • 107
    Solcia E., Rindi G., Fiocca R., Villani L., Riva C. & Capella C. Endocrine proliferations and carcinoids in hypergastrinemia. In: WalshJ. H., ed., Gastrin. Raven, New York , 1993; 36171.
  • 108
    Richards T., Hinder R. A. & Harrison A. C. Gastric carcinoid tumours associated with hypergastrinaemia and pernicious anaemia—regression of tumours by antrectomy. S. Afr. Med. J. 1987; 72: 513.
  • 109
    Eckhauser F. E., Lloyd R. V., Thompson N. W., Raper S. E. & Vinik A. I. Antrectomy for multicentric, argyrophil gastric carcinoids: A preliminary report. Surgery 1988; 104: 104653.
  • 110
    Hirschowitz B. I., Griffith J., Pellegrin D. & Cummings O. W. Rapid regression of enterochromaffinlike cell gastric carcinoids in pernicious anemia after antrectomy. Gastroenterology 1992; 102: 140918.
  • 111
    Hakanson R. & Sundler F. Proposed mechanism of induction of gastric carcinoids: the gastrin hypothesis. Eur. J. Clin. Invest. 1990; 20(Suppl. 1): S6571.
  • 112
    Larsson H., Carlsson E., Mattsson H. et al. Plasma gastrin and gastric enterochromaffinlike cell activation and proliferation. Studies with omeprazole and ranitidine in intact and antrectomized rats. Gastroenterology 1986; 90: 3919.
  • 113
    Larsson H., Carlsson E., Hakanson R. et al. Time-course of development and reversal of gastric endocrine cell hyperplasia after inhibition of acid secretion. Studies with omeprazole and ranitidine in intact and antrectomized rats. Gastroenterology 1988; 95: 147786.
  • 114
    Axelson J., Hakanson R., & Sundler F. Antrectomy does not accelerate reversal of omeprazole-induced trophic effects in the rat stomach. Scand. J. Gastroenterol. 1992; 27: 2438.
  • 115
    Tielemans Y., Axelson J., Sundler F., Willems G. & Hakanson R. Serum gastrin concentration affects the self replication rate of the enterochromaffin like cells in the rat stomach. Gut 1990; 31: 2748.
  • 116
    Brena E. & Waldum H. L. Trophic effect of gastrin on the enterochromaffin like cells of the rat stomach: Establishment of a dose response curve. Gut 1992; 33: 13036.
  • 117
    Hakanson R., Tielemans Y., Chen D., Andersson K., Mattson H. & Sundler F. Time-dependent changes in enterochromaffinlike cells in stomach of hypergastrinemic rats. Gastroenterology 1993; 105: 1521.
  • 118
    Chiba T., Kinoshita Y., Morishita T., Nakata H., Nakamura A. & Hosoda S. Receptors for gastrin on gastric carcinoid tumor membrane of Mastomys natalensis. Biochem. Biophys. Res. Commun. 1991; 177: 73944.
  • 119
    Nakata H., Matsui T., Ito M. et al. Cloning and characterization of gastrin receptor from ECL carcinoid tumor of Mastomys natalensis. Biochem. Biophys. Res. Commun. 1992; 187: 11517.
  • 120
    Eissele R., Patberg H., Koop H. et al. Effect of gastrin receptor blockade on endocrine cells in rats during achlorhydria. Gastroenterology 1992; 103: 1596601.
  • 121
    Nylander A. G., Chen D., Lilja I. et al. Enterochromaffin-like cells in rat stomach respond to short-term infusion of high doses of cholecystokinin but not to longterm, sustained, moderate hyperCCKemia caused by continuous cholecystokinin infusion or pancreaticobiliary diversion. Scand. J. Gastroenterol. 1993; 28: 739.
  • 122
    Stace N. H., Palmer T. J., Vaja S. & Dowling R. H. Longterm pancreaticobiliary diversion stimulates hyperplastic and adenomatous nodules in the rat pancreas: A model for spontaneous tumour formation. Gut 1987; 28(Suppl. 1): 2658.
  • 123
    Morgan R. G. H., Levinson D. A., Hopwood D., Saunders J. H. B. & Wormsley K. G. Potentiation of the action of azaserine on the rat pancreas by raw soya bean flour. Cancer Lett. 1977; 3: 8790.
  • 124
    McGuinness E. E., Morgan R. G. H., Levison D. A., Frape D. L., Hopwood D. & Wormsley K. G. The effects of long-term feeding of soya flour on the rat pancreas. Scand. J. Gastroenterol. 1980; 15: 497502.
  • 125
    Townsend C. M., Singh P. & Thompson J. C. Gastrointestinal hormones and gastrointestinal and pancreatic carcinomas. Gastroenterology 1986; 91: 10026.
  • 126
    Townsend C. M., Beauchamp R. D., Singh P. & Thompson J. C. Growth factors and intestinal neoplasms. Am. J. Surg. 1988; 155: 52736.
  • 127
    Townsend C. M., Singh P. & Thompson J. C. Effects of gastrointestinal peptides on gastrointestinal cancer growth. Gastroenterol. Clin. North Am. 1989; 18: 77791.
  • 128
    Lamers C. B. H. W. & Jansen J. B. M. J. Role of gastrin and cholecystokinin in tumours of the gastrointestinal tract. Eur. J. Cancer Clin. Oncol. 1988; 24: 26773.
  • 129
    Axelson J., Ihse I. & Hakanson R. Pancreatic cancer: The role of cholecystokinin Scand. J. Gastroenterol. 1992; 27: 9938.
  • 130
    Tahara E. & Haizuka S. Effect of gastro-entero-pancreatic endocrine hormones on the histogenesis of gastric cancer in rats induced by N-methyl-N-nitro-N-nitrosoguanidine; with special reference to development of scirrhous gastric cancer. Jpn. J. Cancer Res. (Gann) 1975; 66: 4216.
  • 131
    Tahara E., Shimoto F., Taniyama K., Ito H., Kosako Y. & Sumiyoshi H. Enhanced effect of gastrin on rat stomach carcinogenesis induced by N-methyl-N-nitro-N-nitro- soguanidine. Cancer Res. 1982; 42: 17817.
  • 132
    Kurihara M., Shirakabe H., Yamaya et al. Gastric carcinoma in dogs produced by the combined use of N-methyl-N-nitro-N-nitrosoguanidine (ENNG) and gastrin. Acta Pathol. Jpn. 1979; 29: 1716.
  • 133
    Kishimoto S., Kunita S., Shimizu S. et al. Effects of atrophic changes in mucosa and endogenous gastrin (hypergastrinemia) on development of experimental gastric cancer and its growth in rats: A pilot study. Hiroshima J. Med. Sci. 1983; 32: 21318.
  • 134
    Tatsuta M., Itoh T., Okuda S., Taniguchi H. & Tamura H. Effect of prolonged administration of gastrin on experimental carcinogenesis in rat stomach induced by N-methyl-N-nitro-N-nitrosoguanidine. Cancer Res. 1977; 37: 180810.
  • 135
    Tatsuta M., Itoh T., Okuda S. et al. Effects of gastrin and histamine on gastric carcinogenesis induced in rats by N-methyl-N-nitro-N-nitrosoguanidine. Eur. J. Cancer 1980; 16: 6318.
  • 136
    Tatsuta M., Yamamura H., Taniguchi H. & Tamura H. Gastrin protection against chemically induced gastric adenocarcinomas in Wistar rats: Histopathology of the glandular stomach and incidence of gastric adenocarcinoma. J. Natl Cancer Inst. 1982; 69: 5963.
  • 137
    Deveney C. W., Freeman H. & Way L. W. Experimental gastric carcinogenesis in the rat. Am. J. Surg. 1980; 139: 4954.
  • 138
    Tatsuta M., Iishi H., Ichii M., Noguchi S., Yamamura H. & Taniguchi H. Effect of tetragastrin on the colonic mucosa of rats during intrarectal administration of N-methyl-N-nitro-N-nitrosoguanidine. Cancer Res. 1986; 46: 453942.
  • 139
    Tatsuta M., Yamamura H., Ichii M. & Taniguchi H. Effect of prolonged administration of gastrin on experimental carcinogenesis in rat colon induced by intrarectal instillation of N-methyl-N-nitro-N-nitrosoguanidine. Cancer Res. 1983; 43: 225860.
  • 140
    Tatsuta M., Iishi H., Yamamura H. & Taniguchi H. Inhibition by tetragastrin of experimental carcinogenesis in rat colon: Effect of wheat bran consumption. Int. J. Cancer 1988; 41: 23942.
  • 141
    Tatsuta M., Yamamura H., Iishi H. et al. Effect of a chemically defined diet in liquid form on colon carcinogenesis in rats. J. Natl Cancer Inst. 1985; 75: 91115.
  • 142
    Karlin D. A., McBath M., Jones R. D., Elwyn K. E. & Romsdahl M. M. Hypergastrinemia and colorectal carcinogenesis in the rat. Cancer Lett. 1985; 29: 738.
  • 143
    Oscarson J. E. A., Veen H. F., Ross J. S. & Malt R. A. Dimethylhydrazine-induced colonic neoplasia: Dissociation from endogenous gastrin levels. Surgery 1982; 91: 52530.
  • 144
    Lamers C. B. H. W., Douglas B. R. & Jansen J. B. M. J. Cholecystokinin and pancreatic cancer. Scand J. Gastroenterol. 1988; 23(Suppl. 154): 1036.
  • 145
    Douglas B. R., Woutersen R. A., Jansen J. B. M. J., De Jong A. J. L., Rovati L. C. & Lamers C. B. H. W. Influence of cholecystokinin antagonist on the effects of cholecystokinin and bombesin on azaserine-induced lesions in rat pancreas. Gastroenterology 1989; 96: 4629.
  • 146
    Lhoste E. F. & Longnecker D. S. Effect of bombesin and caerulein on early stages of carcinogenesis induced by azaserine in the rat pancreas. Cancer Res. 1987; 47: 32737.
  • 147
    Bell R. H., Kuhlmann E. T., Jensen R. T. & Longernecker D. S. Overexpression of cholecystokinin receptors in azaserine-induced neoplasms of the rat pancreas. Cancer Res. 1992; 52: 32959.
  • 148
    Douglas B. R., Woutersen R. A., Jansen J. B. M. J., De Jong A. J. I., Rovati L. C. & Lamers C. B. H. W. Modulation by CR-1409 (Lorglumide), a cholecystokinin receptor antagonist, of trypsin inhibitor-enhanced growth of azaserine-induced putative preneoplastic lesions in rat pancreas. Cancer Res. 1989; 49: 243841.
  • 149
    Andrén-Sandberg A., Dawiskiba S. & Ihse I. Studies of the effect of cerulein administration on experimental pancreatic carcinogenesis. Scand J. Gastroenterol. 1984; 19: 1228.
  • 150
    Pour P. M., Lawson T., Helgeson S., Donnelly T. & Stepan K. Effect of cholecystokinin on pancreatic carcinogenesis in the hamster model. Carcinogenesis 1988; 9: 597601.
  • 151
    Meijers M., Van Garderen-Hoetmer A., Lamers C. B. H. W., Rovati L. C., Jansen J. B. M. J. & Woutersen R. A. Role of cholecystokinin in the development of BOP-induced pancreatic lesions in hamsters. Carcinogenesis 1990; 11: 22236.
  • 152
    Howatson A. G. & Carter D. C. Pancreatic carcinogenesis—enhancement by cholecystokinin in the hamster- nitrosamine model. Br. J. Cancer 1985; 51: 10714.
  • 153
    Johnson F. E., LaRegina M. C., Martin S. A. & Bashiti H. M. Cholecystokinin inhibits pancreatic and hepatic carcinogenesis. Cancer Detect Prev. 1983; 6: 389402.
  • 154
    Stewart I. D., Flaks B., Watanapa P., Davies P. W. & Williamson R. C. N. Pancreatobiliary diversion enhances experimental pancreatic carcinogenesis. Br. J. Cancer 1991; 63: 636.
  • 155
    Watanapa P., Flaks B., Oztas H., Deprez P. H., Calam J. & Williamson R. C. N. Enhancing effect of partial gastrectomy on pancreatic carcinogenesis. Br. J. Cancer 1992; 65: 3837.
  • 156
    Ura H., Makino T., Ito S. et al. Combined effects of cholecystectomy and lithocholic acid on pancreatic carcinogenesis of N-nitrosobis(2-hydroxypropyl)amine in Syrian golden hamsters. Cancer Res. 1986; 46: 47826.
  • 157
    McGuinness E. E., Morgan R. G. H., Levison D. A., Hopwood D. & Wormsley K. G. Interaction of azaserine and raw soya flour on the rat pancreas. Scand. J. Gastroenterol. 1981; 16: 4956.
  • 158
    Levison D. A., Morgan R. G. H., Brimacombe J. S., Hopwood D., Coghill G. & Wormsley K. G. Carcinogenic effects of di(2-hydroxypropyl)nitrosamine (DHPN) in male Wistar rats: promotion of pancreatic cancer by a raw soya flour diet. Scand. J. Gastroenterol. 1979; 14: 21724.
  • 159
    Lhoste F., Roebuck B. D. & Longnecker D. S. Stimulation of the growth of azaserine-induced nodules in the rat pancreas by dietary camostate (FOY-305). Carcinogenesis 1988; 9: 9016.
  • 160
    Birt D. F., Salmasi S. & Pour P. M. Enhancement of experimental pancreatic cancer in Syrian golden hamsters by dietary fat. J. Natl Cancer Inst. 1981; 67: 132732.
  • 161
    Herrington M. K., Permert J., Kazakoff K. R. et al. Effects of high fat diet and cholecystokinin receptor blockade on pancreatic growth and tumour initiation in the hamster. Carcinogenesis 1993; 14: 10216.
  • 162
    O'Connor T. P., Roebuck B. D. & Campbell T. C. Dietary intervention during the postdosing phase of L-azaserine-induced preneoplastic lesions. J. Natl Cancer Inst. 1985; 75: 9557.
  • 163
    Appel M. J., Meijers M., Van Garderen-Hoetmer A. et al. Role of cholecystokinin in dietary fat-promoted azaserine-induced pancreatic carcinogenesis in rats. Br. J. Cancer 1992; 66: 4650.
  • 164
    Tatsuta M., Yamamura H., Iishi H., Noguchi S., Ichii M. & Taniguchi H. Gastrin has no promoting effect on chemically induced colonic tumors in Wistar rats. Eur. J. Cancer Clin. Oncol. 1985; 21: 7414.
  • 165
    Elwyn K. E., Jones R. D. & Romsdahl M. M. Inhibitory effects of secretin on gastrin-stimulated rat colon neoplasms. Cancer 1985; 55: 11869.
  • 166
    McGregor D. B., Jones R. D., Karlin D. A. & Romsdahl M. M. Trophic effects of gastrin on colorectal neoplasms in the rat. Ann. Surg. 1982; 195: 21923.
  • 167
    Lamote J. & Willems G. Stimulating effect of pentagastrin on cancer cell proliferation kinetics in chemically induced colon cancer in rats. Reg. Peptides 1988; 20: 19.
  • 168
    Ohkura H., Hanafusa K., Maruyama K., Kitaoka H., Watanabe S. & Kameya T. Gastrin-enhanced tumor growth of a xenotransplantable human gastric carcinoma in nude mice. Jpn. J. Clin. Oncol. 1980; 10: 25564.
  • 169
    Sumiyoshi H., Yashui W., Ochiai A. & Tahara E. Effects of gastrin on tumor growth and cyclic nucleotide metabolism in xenotransplantable human gastric and colonic carcinomas in nude mice. Cancer Res. 1984; 44: 427680.
  • 170
    Tanaka J., Yamaguchi T., Takahashi T., Ogata N., Bando K. & Koyama K. Regulatory effects of gastrin and secretin on carcinomas of the stomach and colon. Tohoku J. Exp. Med. 1986; 148: 45960.
  • 171
    Watson S., Durrant L. & Morris D. Gastrin: Growth enhancing effects on human gastric and colonic tumour cells. Br. J. Cancer 1989; 59: 5548.
  • 172
    Svet-Moldavsky G. J. Dependence of gastro-intestinal tumors on gastro-intestinal hormones: Pentagastrin stimulates growth of transplanted colon adenocarcinoma in mice. Biomedicine 1980; 33: 25961.
  • 173
    Smith J. P. & Solomon T. E. Effects of gastrin, proglumide, and somatostatin on growth of human colon cancer. Gastroenterology 1988; 95: 15418.
  • 174
    Imdahl A., Eggstein S., Crone C. & Farthmann E. H. Growth of colorectal carcinoma cells: Regulation in vitro by gastrin, pentagastrin and the gastrin-receptor antagonist proglumide. J. Cancer Res. Clin. Oncol. 1989; 115: 38892.
  • 175
    Alonso M., Galera M. J., Reyes G., Calabuig R., Vinals A. & Rius X. Effects of pentagastrin and of the somatostatin analog (SMS 201–995) on growth of CT26 in vivo adenocarcinoma of the colon. Surg. Gynecol. Obstet. 1992; 175: 4414.
  • 176
    Smith J. P., Kramer S. T. & Demers L. M. Effects of gastrin and difluoromethylornithine on growth of human colon cancer. Dig. Dis. Sci. 1993; 38: 5208.
  • 177
    Winsett O. E., Townsend C. M., Glass E. J. & Thompson J. C. Gastrin stimulates growth of colon cancer. Surgery 1986; 99: 3027.
  • 178
    Singh P., Walker J. P., Townsend C. M. & Thompson J. C. Role of gastrin and gastrin receptors on the growth of a transplantable mouse colon carcinoma (MC-26) in BALB/c mice. Cancer Res. 1986; 46: 161216.
  • 179
    Smith J. P., Solomon T. E., Bagheri S. & Kramer S. Cholecystokinin stimulates growth of human pancreatic adenocarcinoma SW-1990. Dig. Dis. Sci. 1990; 35: 137784.
  • 180
    Watson S., Durrant L., Elston P. & Morris D. Inhibitory effects of the gastrin receptor antagonist (L-365,260) on gastrointestinal tumor cells. Cancer 1991; 68: 125560.
  • 181
    Townsend C. D., Franklin R. B., Watson L. C., Glass E. J. & Thompson J. C. Stimulation of pancreatic cancer growth by caerulein and secretin. Surg. Forum 1981; 32: 2289.
  • 182
    Hudd C., LaRegina M. C., Devine J. E. et al. Response to exogenous cholecystokinin of six human gastrointestinal cancers xenografted in nude mice. Am. J. Surg. 1989; 157: 38693.
  • 183
    Graffner H., Singh G., Chaudry I. & Milsom J. W. Omeprazole-induced hypergastrinemia does not influence growth of colon carcinoma. Dig. Dis. Sci. 1992; 37: 4859.
  • 184
    Hudd C., Euhus D. M., LaRegina M. C., Herbold D. R., Palmer D. C. & Johnson F. E. Effect of cholecystokinin on human cholangiocarcinoma xenografted into nude mice. Cancer Res. 1985; 45: 13727.
  • 185
    Yasui W., Sumiyoshi H., Ochiai A. & Tahara E. Cholecystokinin inhibition of tumor growth and gastrin-stimulated cyclic adenosine 3′: 5′-monophosphate metabolism in human gastric carcinoma in nude mice. Cancer Res. 1986; 46: 7403.
  • 186
    Karsenty L., Hajri A., Aprahamian M., Garaud J-C, Doffoel M. & Damge C. Inhibition of growth of a transplanted rat pancreatic acinar carcinoma with CCK-8. Pancreas 1993; 8: 20411.
  • 187
    Watson S. A., Crosbee D. M., Morris D. L. et al. Therapeutic effect of the gastrin receptor antagonist, CR2093 on gastrointestinal tumour cell growth. Br. J. Cancer 1992; 65: 87983.
  • 188
    Harrison J. D., Jones J. A. & Morris D. L. The effect of the gastrin receptor antagonist proglumide on survival in gastric carcinoma. Cancer 1990; 66: 144952.
  • 189
    Imdahl A., Eggstein S., Strik M. & Farthmann E. H. Growth of transplanted human colon carcinomas in nude rats: Influence of gastrin level modulation and gastrin receptor status. Contrib. Oncol. 1992; 42: 6676.
  • 190
    Smith J. P., Kramer S. & Bagheri S. Effects of a high-fat diet and L364-718 on growth of human pancreas cancer. Dig. Dis. Sci. 1990; 35: 72632.
  • 191
    Evers B. M., Gomez G., Townsend C. M., Rajaraman S. & Thompson J. C. Endogenous cholecystokinin regulates growth of human cholangiocarcinoma. Ann. Surg. 1989; 210: 31723.
  • 192
    Abbruzzese J. L., Gholson C. F., Daugherty K. et al. A pilot clinical trial of the cholecystokinin receptor antagonist MK-329 in patients with advanced pancreatic cancer. Pancreas 1992; 7: 16571.
  • 193
    Aspegren K., Eriksson S., Liedberg G. & Trope C. In vitro responsiveness of human gastric carcinoma to pentagastrin. Scand. J. Gastroenterol. 1977; 12: 2536.
  • 194
    Sirinek K. R., Levine B. A. & Moyer P. M. Pentagastrin stimulates in vitro growth of normal and malignant human colon epithelial cells. Am. J. Surg. 1985; 149: 359.
  • 195
    Watson S. A., Durrant L. G. & Morris D. L. Growth-promoting action of gastrin on human colonic and gastric tumour cells cultured in vitro. Br. J. Surg. 1988; 75: 3425.
  • 196
    Moyer M. P., Armstrong A., Aust J. B., Levine B. A. & Sirinek K. R. Effects of gastrin, glutamine, and somatostatin on the in vitro growth of normal and malignant human gastric mucosal cells. Arch. Surg. 1986; 121: 2858.
  • 197
    Watson S. A., Durrant L. G., Crosbie J. D. & Morris D. L. The in vitro growth response of primary human colorectal and gastric cancer cells to gastrin. Int. J. Cancer 1989; 43: 6926.
  • 198
    Ochiai A., Yasui W. & Tahara E. Growth-promoting effect of gastrin on human gastric carcinoma cell line TMK-1. Jpn. J. Cancer Res. (Gann) 1985; 76: 106471.
  • 199
    Piontek M. K. & Hengels K. J. Differential mode of action of high- and low-affinity CCK/gastrin receptor antagonists in growth inhibition of gastrin-responsive human gastric adenocarcinoma cells in vitro. Anticancer Res. 1993; 13: 71520.
  • 200
    Ishizuka J., Martinez J., Townsend C. M. & Thompson J. C. The effect of gastrin on growth of human stomach cancer cells. Ann. Surg. 1992; 215: 52835.
  • 201
    Kobori O., Vuillot M. T. & Martin F. Growth responses of rat stomach cancer cells to gastro-entero-pancreatic hormones. Int. J. Cancer 1982; 30: 657.
  • 202
    Murakami H. & Masui H. Hormonal control of human colon carcinoma cell growth in serum-free medium. Proc. Natl Acad. Sci. USA 1980; 77: 34648.
  • 203
    Townsend C. M., Ishizuka J. & Thompson J. C. Gastrin trophic effects on transplanted colon cancer cells. In: WalshJ. H., ed., Gastrin. Raven, New York , 1993; 40717.
  • 204
    Kiss R., Salmon I., Pauwels O. et al. In vitro influence of gastrin, oestradiol and gonadotropin-releasing hormone on HCT-15 and LoVo human colorectal neoplastic cell proliferation. Eur. J. Cancer 1991; 27: 126874.
  • 205
    Kusyk C. J., McNiel N. O. & Johnson L. R. Stimulation of growth of a colon cancer cell line by gastrin. Am. J. Physiol. 1986; 251: G597601.
  • 206
    Eggstein S., Imdahl A., Kohler M., Waibel M. & Farthmann E. H. Influence of gastrin, gastrin receptor blockers, epidermal growth factor, and difluoromethyl-ornithine on the growth and the activity of ornithine decarboxylase of colonic carcinoma cells. J. Cancer Res. Clin. Oncol. 1991; 117: 3742.
  • 207
    Guo Y. S., Baijal M., Jin G. F., Thompson J. C., Townsend C. M. & Singh P. Growth-promoting effects of gastrin on mouse colon cancer cells in vitro: Absence of autocrine effects. In Vitro Cell. Dev. Biol. 1990; 26: 8717.
  • 208
    Smith J. P., Kramer S. T. & Solomon T. E. CCK stimulates growth of six human pancreatic cancer cell lines in serum-free medium. Reg. Peptides 1991; 32: 3419.
  • 209
    Smith J. P., Rickabaugh C. A., McLaughlin P. J. & Zagon I. S. Cholecystokinin receptors and PANC-1 human pancreatic cancer cells. Am. J. Physiol. 1993; 265: G14955.
  • 210
    Liehr R. M., Melnykovych G. & Solomon T. E. Growth effects of regulatory peptides on human pancreatic cancer lines PANC-1 and MIA PaCa-2. Gastroenterology 1990; 98: 166674.
  • 211
    Seva C., Scemama J. L., Bastié M. J., Pradayrol L. & Vaysse N. Lorglumide and loxiglumide inhibit gastrin-stimulated DNA synthesis in a rat tumoral acinar pancreatic cell line (AR42J). Cancer Res. 1990; 50: 582933.
  • 212
    Conteas C. N. & Nandi Majumdar A. P. The effects of gastrin, epidermal growth factor, and somatostatin on DNA synthesis in a small intestinal crypt cell line (IEC-6). Proc. Soc. Exp. Biol. Med. 1987; 184: 30711.
  • 213
    Weinstock J. & Baldwin G. S. Binding of gastrin17 to human gastric carcinoma cell lines. Cancer Res. 1988; 48: 9327.
  • 214
    Durrant L. G., Watson S. A., Hall A. & Morris D. L. Co-stimulation of gastrointestinal tumour cell growth by gastrin, transforming growth factor α and insulin like growth factor-I. Br. J. Cancer 1991; 63: 6770.
  • 215
    Wang T. C., Bonner-Weir S., Oates P. S. et al. Pancreatic gastrin stimulates islet cell differentiation of transforming growth factor α-induced ductular precursor cells. J. Clin. Invest. 1993; 92: 134956.
  • 216
    Lambert M., Bui N. D. & Christophe J. Functional and molecular characterization of CCK receptors in the rat pancreatic acinar cell line AR 4–2J. Reg. Peptides 1991; 32: 15167.
  • 217
    Scemama J. L., De Vries L., Pradayrol L., Seva C., Tronchere H. & Vaysse N. Cholecystokinin and gastrin peptides stimulate ODC activity in a rat pancreatic cell line. Am. J. Physiol. 1989; 256: G84650.
  • 218
    Heald E. B., Kramer S. T. & Smith J. P. Trophic effects of unsulfated cholecystokinin on mouse pancreas and human pancreatic cancer. Pancreas 1992; 7: 5305.
  • 219
    Frucht H., Gazdar A. F., Park J-A., Oie H. & Jensen R. T. Characterization of functional receptors for gastrointestinal hormones on human colon cancer cells. Cancer Res. 1992; 52: 111422.
  • 220
    Park J-G., Frucht H., Larocca R. V. et al. Characteristics of cell lines established from human gastric carcinoma. Cancer Res. 1990; 50: 277380.
  • 221
    Van Solinge W. W., Nielsen F. C., Friis-Hansen L., Falkmer U. G. & Rehfeld J. F. Expression but incomplete maturation of progastrin in colorectal carcinomas. Gastroenterology 1993; 104: 10991107.
  • 222
    Finley G. G., Koski R. A., Melhem M.F., Pipas J. M. & Meisler A. I. Expression of the gastrin gene in the normal human colon and colorectal adenocarcinoma. Cancer Res. 1993; 53: 291926.
  • 223
    Baldwin G. S., Casey A., Mantamadiotis T., McBride K., Sizeland A. M. & Thumwood C. M. PCR cloning and sequence of gastrin mRNA from carcinoma cell lines. Biochem. Biophys. Res. Comm. 1990; 170: 6917.
  • 224
    Van Solinge W. W. & Rehfeld J. F. Co-transcription of the gastrin and cholecystokinin genes with selective translation of gastrin mRNA in a human gastric carcinoma cell line. FEBS Lett. 1992; 309: 4750.
  • 225
    Baldwin G. S. & Zhang Q-X. Measurement of gastrin and transforming growth factor α messenger RNA levels in colonic carcinoma cell lines by quantitative polymerase chain reaction. Cancer Res. 1992; 52: 22617.
  • 226
    Tahara E., Ito H., Nakagami K., Shimamoto F., Yamamoto M. & Sumii K. Scirrhous argyrophil cell carcinoma of the stomach with multiple production of polypeptide hormones, amine, CEA, lysozyme, and HCG. Cancer 1982; 49: 190415.
  • 227
    Watson S. A., Durrant L. G., Wencyk P. M., Watson A. L. & Morris D. L. Intracellular gastrin in human gastrointestinal tumor cells. J. Natl Cancer Inst. 1991; 83: 86671.
  • 228
    Nemeth J., Taylor B., Pauwels S., Varro A. & Dockray G. J. Identification of progastrin derived peptides in colorectal carcinoma extracts. Gut 1993; 34: 905.
  • 229
    Kochman M. L., DelValle J., Dickinson C. J. & Boland C. R. Post-translational processing of gastrin in neoplastic human colonic tissues. Biochem. Biophys. Res. Commun. 1992; 189: 11659.
  • 230
    Hoosein N. M., Kiener P. A., Curry R. C. & Brattain M. G. Evidence for autocrine growth stimulation of cultured colon tumor cells by a gastrin/cholecystokinin-like peptide. Exp. Cell Res. 1990; 186: 1521.
  • 231
    Remy-Heintz N., Perrier-Missonier S., Nonotte I. et al. Evidence for autocrine growth stimulation by a gastrin/CCK-like peptide of the gastric cancer HGT-1 cell line. Mol. Cell Endocrinol. 1993; 93: 239.
  • 232
    Smith J. P., Wood J. G. & Solomon T. E. Elevated gastrin levels in patients with colon cancer or adenomatous polyps. Dig. Dis. Sci. 1989; 34: 1714.
  • 233
    Wong K., Beardshall K., Waters C. M., Calam J. & Poston G. J. Postprandial hypergastrinaemia in patients with colorectal cancer. Gut 1991; 32: 13524.
  • 234
    Suzuki H., Matsumoto K. & Torashima H. Serum levels of gastrin in patients with colorectal neoplasia. Dis. Colon Rectum 1988; 31: 71617.
  • 235
    Kikendall J. W., Glass A. R., Sobin L. H. & Bowen P. E. Serum gastrin is not higher in subjects with colonic neoplasia. Am. J. Gastroenterol. 1992; 87: 13947.
  • 236
    Yapp R., Modlin I. M., Kumar R. R., Binder H. J. & Dubnow R. Gastrin and colorectal cancer. Dig. Dis. Sci. 1992; 37: 4814.
  • 237
    Kameyama M., Fukuda I., Imaoka S., Nakamori S. & Iwanaga T. Level of serum gastrin as a predictor of liver metastasis from colorectal cancer. Dis. Colon Rectum 1993; 36: 497500.
  • 238
    Beauchamp D. R., Townsend C. M., Singh P., Glass E. J. & Thompson J. C. Proglumide, a gastrin receptor antagonist, inhibits growth of colon cancer and enhances survival in mice. Ann. Surg. 1985; 202: 3039.
  • 239
    Singh P., Le S., Beauchamp R. D., Townsend C. M. & Thompson J. C. Inhibition of pentagastrin-stimulated up-regulation of gastrin receptors and growth of mouse colon tumor in vivo by proglumide, a gastrin receptor antagonist. Cancer Res. 1987; 47: 50004.
  • 240
    Thumwood C. M., Ji H. & Baldwin G. S. Inhibition of cell proliferation by the cholecystokinin antagonist L-364718. Exp. Cell Res. 1991; 192: 18992.
  • 241
    Pradel P., Estival A., Seva C. et al. Caerulein and gastrin(2-17 ds) regulate differently synthesis of secretory enzymes, mRNA levels and cell proliferation in pancreatic acinar cells (AR4-2J). Biochem. J. 1993; 290: 21924.
  • 242
    Watson S. A., Morris D. L., Durrant L. G., Robertson J. F. & Hardcastle J. D. Inhibition of gastrin-stimulated growth of gastrointestinal tumour cells by octreotide and the gastrin/cholecystokinin receptor antagonists, proglumide and lorglumide. Eur. J. Cancer 1992; 28A: 14627.
  • 243
    Zhou W., Povoski S. P., Longnecker D. S. & Bell R. H. Novel expression of gastrin (cholecystokinin-B) receptors in azaserine-induced rat pancreatic carcinoma: receptor determination and characterization. Cancer Res. 1992; 52: 690511.
  • 244
    Singh P., Rae-Venter B., Townsend C. M., Khalil T. & Thompson J. C. Gastrin receptors in normal and malignant gastrointestinal mucosa: age-associated changes. Am. J. Physiol. 1985; 249: G7619.
  • 245
    Upp J. R., Singh P., Townsend C. M. & Thompson J. C. Clinical significance of gastrin receptors in human colon cancers. Cancer Res. 1989; 49: 48892.
  • 246
    Murphy V. J., McBride K., Ji Hong & Baldwin G. S. Effects of proglumide on cell growth: Evidence against an autocrine role for extracellular gastrin. Gastrointest. Cancer 1994 (in press).
  • 247
    Baldwin G. S. Gastrin and the transforming protein of polyoma virus have evolved from a common ancestor. FEBS Lett. 1982; 137: 15.
  • 248
    Baldwin G. S., Knesel J. & Monckton J. M. Phosphorylation of gastrin-17 by epidermal growth factor-stimulated tyrosine kinase. Nature 1983; 301: 4357.
  • 249
    Carpenter C. L. & Cantley L. C. Phosphoinositide kinases. Biochemistry 1990; 29: 1114756.
  • 250
    Songyang Z., Shoelson S. E., Chaudhuri M. et al. SH2 domains recognize specific phosphopeptide sequences. Cell 1993; 72: 76778.